• Events
  • News & Publicity
  • Publications
  • Contact CEET
Perelman School of Medicine
Header
  • Home
    • About the CEET
    • CEET Blog
    • Penn SRP Center
    • AKR Superfamily
  • Members & Themes
    • CEET Membership
    • Air Pollution & Lung Health (AP)
    • Environmental Exposures and Cancer (EC)
    • Windows-of-Susceptibility (WS)
    • Environmental Neuroscience (EN)
    • Community Engagement Core (CEC)
  • Cores
    • Core List
      • Integrative Health Sciences Facility Core (IHSFC)
      • Translational Biomarker Core
      • Exposure Biology Informatics Core (EBIC)
    • Service Request
    • Usage Summary
  • Training & Career Development
    • Summer Programs
    • Environmental Health Sciences Certificate Program
    • Training Grant in Environmental Health Sciences
    • Career Development Activities
  • Funding
    • CEET Mentored Scientist Transition Award (MSTA)
    • Pilot
    • NIH
    • ONES Award
  • Engagement
    • For Community Members
    • Environmental Health Education Programs
    • For Health Care Professionals
    • For Policy Makers
    • Community Engagement Core (CEC)
    • CEC Blog
    • PA General Assembly Environmental Health Legislative Watch
    • Contact CEC
  • Target Communities
    • West Philadelphia
    • South Philadelphia
    • Chester
      • Chester Environmental Partnership Presents:
    • Eastwick
    • Lancaster County
    • Northeast Pennsylvania Communities with Hydraulic Fracturing
    • Ambler

Archive for COPD

May is Asthma Awareness Month!

Posted by Adrian Hoppel 
· Thursday, May 22nd, 2014 
· No Comments

May is Asthma Awareness Month!ReyBlog1

We are going to highlight the Integrative Health Sciences Facility Core (IHSFC) and the Lung and Airway Disease Affinity Group and its work on asthma with Dr. Reynold Panettieri

Integrative Health Sciences Facility Core (IHSFC)

The Integrative Health Sciences Facility Core (IHSFC) focuses on identifying important research questions that can directly address human disease.

What We Do?

In the Lung and Airway Disease Affinity Group, we focus on understanding the cause of asthma and COPD with a focus on new therapeutic agents. Our research at the Lung and Airway Disease Affinity Group and IHSFC is unique.  We are one of seven centers nationwide that have a human exposure chamber to directly test hypotheses related to human health.  Additionally, we have new experimental platforms using human cells that greatly enhance the relevance of our work. Our laboratory has been active for the past 22 years and has specifically focused on novel therapeutics in the treatment of COPD and asthma.  Although we have a legacy of research in this area, our focus is always on using up-to-date, state-of-the-art approaches to address problems.

Who We Help?

We help children and adults who have or are affected by asthma. Asthma rates in Philadelphia are some of the highest in the country. In some neighborhoods, asthma rates are as high as 26%!

What’s New and Exciting?

Our recent evidence suggests that vitamin D is a critical therapeutic that can improve airway obstruction and inflammation seen in asthma and COPD.  We are optimistic that the development of vitamin D inhaled solutions may greatly impact human health.

How Can You Get Involved?

Our laboratories are consistently recruiting research subjects for a number of important studies in asthma and COPD. Visit our website (http://www.med.upenn.edu/airways/), to learn more about opportunities to participate in our research.

Follow #IamEH for all of our posts and learn about what environmental health questions are being asked all over the country!

No Comments
Categories : CEET Blog
Tags : air pollution, airway, asthma, COPD, IHSFC, lung, NIEHS, ozone, research

© The Trustees of the University of Pennsylvania | University of Pennsylvania | Perelman School of Medicine